Explore the benefits and considerations of adjuvant immunotherapy in the treatment of resectable non-small cell lung cancer (NSCLC). Review the latest clinical trials, including IMpower 010 and Checkmate 816, and learn about the potential role of neoadjuvant therapy.

11 views • 28 slides

POSNOC (Positive Sentinel Node) and ATNEC trials are investigating the effectiveness of axillary treatment in women with early-stage breast cancer having metastases in one or two sentinel nodes. Led by Chief Investigator Amit Goyal in the UK, this randomized controlled trial compares adjuvant therap

1 views • 21 slides

In the management of rectal cancer, the debate between surgical resection and organ preservation after neoadjuvant chemoradiotherapy is ongoing. While surgical resection is highly effective, the watch-and-wait strategy offers benefits such as avoiding permanent stomas and improving quality of life.

1 views • 14 slides

Discussing the role of neoadjuvant therapy in breast cancer management, this presentation by Dr. Christine Simmons covers current Canadian guidelines, historical perspectives, benefits of neoadjuvant therapy in drug development, and clinical importance in rendering inoperable patients operable. The

0 views • 32 slides

Explore the potential treatments for a 83-year-old male diagnosed with Stage III rectal cancer, including surgery, radiation therapy, chemotherapy, and immunotherapy. Learn about neoadjuvant and adjuvant therapies, complete response definitions, surgical techniques like total mesorectal excision (TM

0 views • 32 slides

NSABP conducted various adjuvant and neoadjuvant trials (B-15, B-18, B-22, B-23, B-28, B-30, B-27, B-40) involving different treatment arms and patient populations with operable breast cancer. Trials included chemotherapy regimens with Adriamycin, cyclophosphamide, tamoxifen, and radiation therapy,

0 views • 11 slides